Abstract
Glycogen storage disease type III (GSD III) is an autosomal recessive disorder caused by deficiency in the glycogen debranching enzyme (gene symbol: AGL) with two enzyme activities: transferase and glucosidase. A missense mutation causing isolated glucosidase deficiency has never been reported. In this study, we examined 23 patients of Turkish ancestry and identified a novel missense mutation p.R1147G with isolated glucosidase deficiency, along with nine AGL mutations: six nonsense mutations (p.W373X, p.R595X, p.Q667X, p.Q1205X, p.W1327X and p.Q1376X), one deletion (c.1019delA) and two splicing mutation (c.293+2T>G and c.958+1G>A). As p.R1147G impaired glucosidase activity, but maintained transferase activity in vitro, a 12-year-old girl homozygous for p.R1147G was diagnosed with having isolated glucosidase deficiency. Of nine other mutations, p.W1327X and c.1019delA were recurrent, whereas seven mutations were novel. Six patients with p.W1327X were all from two nearby cities on the East Black Sea and shared the same AGL haplotype, indicating a founder effect in Turkish patients. Patients with the same mutations had identical haplotypes. Our results provide the first comprehensive overview of clinical and molecular features of Turkish GSD III patients and the first description of the missense mutation associated with isolated glucosidase deficiency.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Accession codes
References
Chen, Y. T. in The Metabolic and Molecular Bases of Inherited Disease, 8th edn. (eds. Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 1521–1551 (McGraw-Hill, New York, 2001).
Shin, Y. S. Glycogen storage disease: clinical, biochemical, and molecular heterogeneity. Semin. Pediatr. Neurol. 13, 115–120 (2006).
Hers, H. G., Verhue, W. & Mathieu, M. in Control of Glycogen Metabolism (eds. Whelan, W.J. & Cameron, M.P.) 151–175 (J. & A. Churchill, London, 1964).
Van Hoof, F. & Hers, H. G. The subgroups of type 3 glycogenosis. Eur. J. Biochem. 2, 265–270 (1967).
Howell, R. R. & Williams, J. C. in The Metabolic Basis of Inherited Disease, 5th edn. (eds. Stanbury, J.B., Wyngaarden, J.B., Fredrickson, D.S., Goldstein, J.L. & Brown, M.S.) 141–166 (McGraw-Hill, New York, 1983).
Shen, J., Bao, Y., Liu, H. M., Lee, P., Leonard, J. V. & Chen, Y. T. Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J. Clin. Invest. 98, 352–357 (1996).
Cheng, A., Zhang, M., Okubo, M., Omichi, K. & Saltiel, A. R. Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions. Hum. Mol. Genet. 18, 2045–2052 (2009).
Bao, Y., Dawson, T. L. Jr. & Chen, Y. T. Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5′ flanking region. Genomics 38, 155–165 (1996).
Sugie, H., Fukuda, T., Ito, M., Sugie, Y., Kojoh, T. & Nonaka, I. Novel exon 11 skipping mutation in a patient with glycogen storage disease type IIId. J. Inherit. Metab. Dis. 24, 535–545 (2001).
Endo, Y., Fateen, E., El Shabrawy, M., Aoyama, Y., Ebara, T., Murase, T. et al. Egyptian glycogen storage disease type III-Identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId. Clin. Chem. Lab. Med. 47, 1233–1238 (2009).
Santer, R., Kinner, M., Steuerwald, U., Kjaergaard, S., Skovby, F., Simonsen, H. et al. Molecular genetic basis and prevalence of glycogen storage disease type IIIA in the Faroe Islands. Eur. J. Hum. Genet. 9, 388–391 (2001).
Parvari, R., Moses, S., Shen, J., Hershkovitz, E., Lerner, A. & Chen, Y. T. A single-base deletion in the 3′-coding region of glycogen-debranching enzyme is prevalent in glycogen storage disease type IIIA in a population of North African Jewish patients. Eur. J. Hum. Genet. 5, 266–270 (1997).
Okubo, M., Horinishi, A., Takeuchi, M., Suzuki, Y., Sakura, N., Hasegawa, Y. et al. Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan. Hum. Genet. 106, 108–115 (2000).
Lucchiari, S., Pagliarani, S., Salani, S., Filocamo, M., Di Rocco, M., Melis, D. et al. Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL. Hum. Mutat. 27, 600–601 (2006).
Shaiu, W. L., Kishnani, P. S., Shen, J., Liu, H. M. & Chen, Y. T. Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease. Mol. Genet. Metab. 69, 16–23 (2000).
Endo, Y., Horinishi, A., Vorgerd, M., Aoyama, Y., Ebara, T., Murase, T. et al. Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey. J. Hum. Genet. 51, 958–963 (2006).
Aoyama, Y., Endo, Y., Ebara, T., Murase, T., Shin, Y. S., Podskarbi, T. et al. A novel AGL mutation in a Turkish patient with glycogen storage disease type IIIa. Pediatr. Int. (in press).
Shin, Y. S., Ungar, R., Rieth, M. & Endres, W. A simple assay for amylo-1,6-glucosidase to detect heterozygotes for glycogenosis type III in erythrocytes. Clin. Chem. 30, 1717–1718 (1984).
Endo, Y., Fateen, E., Aoyama, Y., Horinishi, A., Ebara, T., Murase, T. et al. Molecular characterization of Egyptian patients with glycogen storage disease type IIIa. J. Hum. Genet. 50, 538–542 (2005).
Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H. et al. Clustal W and Clustal X version 2.0. Bioinformatics. 23, 2947–2948 (2007).
Hadjigeorgiou, G. M., Comi, G. P., Bordoni, A., Shen, J., Chen, Y. T., Salani, S. et al. Novel donor splice site mutations of AGL gene in glycogen storage disease type IIIa. J. Inherit. Metab. Dis. 22, 762–763 (1999).
Nalla, V. K. & Rogan, P. K. Automated splicing mutation analysis by information theory. Hum. Mutat. 25, 334–342 (2005). Erratum in Hum. Mutat. 29, 1168 (2008).
Nakayama, A., Yamamoto, K. & Tabata, S. Identification of the catalytic residues of bifunctional glycogen debranching enzyme. J. Biol. Chem. 276, 28824–28828 (2001).
Lucchiari, S., Donati, M. A., Parini, R., Melis, D., Gatti, R., Bresolin, N. et al. Molecular characterisation of GSD III subjects and identification of six novel mutations in AGL. Hum. Mutat. 20, 480 (2002).
Schoser, B., Glaser, D. & Muller-Hocker, J. Clinicopathological analysis of the homozygous p.W1327X AGL mutation in glycogen storage disease type 3. Am. J. Med. Genet. 146A, 2911–2915 (2008).
Acknowledgements
This study was supported in part by a research grant from the Nakatomi Foundation. We thank Yuichi Kondo for his technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aoyama, Y., Ozer, I., Demirkol, M. et al. Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations. J Hum Genet 54, 681–686 (2009). https://doi.org/10.1038/jhg.2009.100
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2009.100
Keywords
This article is cited by
-
Intron retention is among six unreported AGL mutations identified in Malaysian GSD III patients
Genes & Genomics (2019)
-
Myopathies Related to Glycogen Metabolism Disorders
Neurotherapeutics (2018)
-
Crystal structure of glycogen debranching enzyme and insights into its catalysis and disease-causing mutations
Nature Communications (2016)
-
A mutation analysis of the AGL gene in Korean patients with glycogen storage disease type III
Journal of Human Genetics (2014)
-
Molecular and biochemical characterization of a novel intronic single point mutation in a Tunisian family with glycogen storage disease type III
Molecular Biology Reports (2013)
